2024 state of the advanced therapy industry report has been saved
Article
2024 state of the advanced therapy industry report
Trends shaping the future of personalized medicine
What’s on the horizon for the advanced therapy market? Our survey of advanced therapies developers, advanced therapies manufacturing organizations, and health care providers and payers highlights a shared optimism—and pinpoints key areas to watch in the next 12–18 months. Explore cell and gene therapy insights that can help steer decision-making in the future of personalized medicine.
Seven insights from the frontlines of advanced therapy
Dive into the major findings from our 2024 state of the advanced therapy industry report, highlighting important trends and insights from more than 376 industry stakeholders across the cell and gene therapy market. Our survey, expanded this year to capture diverse viewpoints from developers to health care providers, sheds light on optimism in the industry, growth strategies, and pressing challenges.
Secure your copy of the 2024 state of the advanced therapy industry report
Stay ahead of the curve in the rapidly evolving cell and gene therapy market. Complete the form below to pre-register for an exclusive copy of the full report, launching early this fall. It provides an in-depth analysis of the transformative impact of advanced therapy medicinal products so your organization can shape its strategic planning for the year ahead.
Contact us to learn more
Get in touch
Hussain Mooraj |
Amit Agarwal |
|
|
Jessica Faust |
Rajesh Singh |
Recommendations
2023 cell and gene therapy industry survey
Advancing the future of personalized medicine
Closing the cost gap: Strategies to advance women’s health equity
Rethinking benefit coverage and affordability